China National Medicines Corporation Ltd. (SHA:600511)

SHA:600511 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,431	25,819	21,594	21,051	23,789	37,205
Market Cap Growth	-9.64%	19.57%	2.58%	-11.51%	-36.06%	80.69%
Enterprise Value	16,315	20,034	15,889	16,871	19,902	34,465
Last Close Price	29.73	33.30	27.14	25.91	28.55	43.93
PE Ratio	11.22	12.91	10.06	10.72	13.56	26.91
Forward PE	10.46	10.71	8.91	10.01	12.87	19.84
PS Ratio	0.44	0.51	0.44	0.46	0.51	0.92
PB Ratio	1.15	1.36	1.23	1.33	1.66	2.84
P/TBV Ratio	1.31	1.55	1.41	1.53	1.93	3.39
P/FCF Ratio	16.41	16.89	8.37	9.29	12.77	30.18
P/OCF Ratio	15.10	15.56	7.92	8.79	12.15	28.58
PEG Ratio	3.49	2.37	2.37	2.37	2.37	2.37
EV/Sales Ratio	0.32	0.40	0.32	0.37	0.43	0.85
EV/EBITDA Ratio	6.98	9.05	6.39	6.96	9.24	20.65
EV/EBIT Ratio	7.75	9.52	6.70	7.28	9.69	22.01
EV/FCF Ratio	11.93	13.11	6.16	7.45	10.69	27.96
Debt / Equity Ratio	0.04	0.05	0.03	0.03	0.05	0.06
Debt / EBITDA Ratio	0.37	0.36	0.21	0.21	0.31	0.46
Debt / FCF Ratio	0.63	0.55	0.21	0.23	0.38	0.65
Asset Turnover	1.51	1.50	1.60	1.58	1.76	1.65
Inventory Turnover	10.19	10.54	11.90	11.53	13.05	11.63
Quick Ratio	1.72	1.68	1.73	1.71	1.63	1.68
Current Ratio	2.09	2.04	2.04	2.02	1.93	1.97
Return on Equity (ROE)	11.31%	11.67%	13.98%	14.09%	14.05%	11.95%
Return on Assets (ROA)	3.87%	3.90%	4.78%	5.03%	4.85%	3.99%
Return on Capital (ROIC)	6.77%	6.94%	8.61%	9.22%	8.87%	7.35%
Return on Capital Employed (ROCE)	10.20%	10.50%	12.80%	13.70%	13.50%	11.50%
Earnings Yield	8.91%	7.75%	9.94%	9.33%	7.37%	3.72%
FCF Yield	6.10%	5.92%	11.96%	10.76%	7.83%	3.31%
Dividend Yield	2.69%	2.40%	3.15%	3.02%	2.45%	1.25%
Payout Ratio	31.46%	34.12%	33.06%	31.16%	36.36%	44.34%
Buyback Yield / Dilution	0.01%	-0.00%	0.00%	0.00%	-0.00%	0.98%
Total Shareholder Return	2.70%	2.40%	3.15%	3.02%	2.45%	2.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.